A Double‐Blind Comparative Study of burstDR Versus Tonic Epidural Motor Cortex Stimulation for the Treatment of Intractable Neuropathic Pain - Équipe NeuroPain du CRNL : Intégration Centrale de la Douleur chez l'Homme
Article Dans Une Revue European Journal of Pain Année : 2025

A Double‐Blind Comparative Study of burstDR Versus Tonic Epidural Motor Cortex Stimulation for the Treatment of Intractable Neuropathic Pain

Résumé

ABSTRACT Background Preliminary studies on epidural motor cortex stimulation (eMCS) for the treatment of drug‐resistant neuropathic pain have supported the extension to novel stimulation waveforms, in particular burstDR. However, only a low level of evidence is available. The aim of this retrospective observational study was to compare the analgesic efficacy of burstDR versus tonic eMCS. Methods Patients suffering from unilateral, drug‐resistant neuropathic pain were selected for eMCS. During the trial phase, burstDR and tonic waveforms were successively applied for three consecutive months in a double‐blinded fashion and in a random order. The primary outcome criterion was the percentage of pain relief (%PR) at 3 and 6 months. The secondary outcome criterion was the proportion of patients reporting a superior %PR with the burstDR waveform. Results Thirteen patients were included. The averaged %PR was 75.4% ± 18.6% after burstDR eMCS and 61.1% ± 28.6% after tonic eMCS ( p = 0.21). Nine patients preferred the burstDR waveform for chronic eMCS ( p = 0.16), and six of them were able to decrease or withdraw their analgesic drug intake. No adverse side effect was encountered in relation to burstDR eMCS. Conclusions BurstDR eMCS seems at least as effective as tonic eMCS for the treatment of drug‐resistant neuropathic pain and shows a similar safety profile. Although the precise mechanisms of action remain to be fully elucidated, adequate matching between the oscillatory rhythm in the motor cortex and that of the burstDR waveform may increase synaptic efficacy, thus enhancing the functional connectivity of the motor cortex with remote brain networks involved in pain modulation. Significance Statement In the present paper, we provide for the first time a double‐blinded study comparing burstDR versus tonic eMCS for the treatment of intractable, drug‐resistant neuropathic pain. Our results show that burstDR eMCS is a promising option in a population of patients especially difficult to treat, and support the ongoing move toward new stimulation waveforms able to more efficiently activate the brain networks involved in pain modulation.
Fichier principal
Vignette du fichier
2025Seznec25ThetaBurstSCM.pdf (343.1 Ko) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-04878653 , version 1 (10-01-2025)

Identifiants

Citer

Yann Seznec, Joy Thomas, Pelletier Jean Baptiste, Benjamin Buhot, Philippe Convers, et al.. A Double‐Blind Comparative Study of burstDR Versus Tonic Epidural Motor Cortex Stimulation for the Treatment of Intractable Neuropathic Pain. European Journal of Pain, 2025, 29 (2), ⟨10.1002/ejp.4778⟩. ⟨hal-04878653⟩
0 Consultations
0 Téléchargements

Altmetric

Partager

More